Verification evidence is still being completed.
PDF / print export
Fuse Vectors ApS
Copenhagen, Denmark
- Verified lead
- Jordan Turnbull
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Co-Chief Executive Officer and Co-Founder
- 2026 technical specialization
- Cell-Free Viral Vector Manufacturing, AAV Scalability, and Gene Therapy CMC
- Review cycle
- 24 April 2026
- Full address
- BioInnovation Institute, Tuborg Havnevej 19, 2900 Hellerup, Denmark
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Fuse Vectors February 2025 funding release confirming Jordan Turnbull as Co-CEO and co-founder.
- Editorial note
- Copenhagen cell-free AAV manufacturing platform biotech with named co-founder Co-CEO, HCVC- and BII-backed 5.2 million USD pre-seed, and an active Leiden R&D site.
Cell-Free Viral Vector Manufacturing, AAV Scalability, and Gene Therapy CMC
Pre-seed platform stage, BII Copenhagen portfolio, Leiden Bioscience Park presence
Copenhagen cell-free AAV manufacturing platform biotech with named co-founder Co-CEO, HCVC- and BII-backed 5.2 million USD pre-seed, and an active Leiden R&D site.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Copenhagen, Denmark
Fuse Vectors ApS
Cell-Free Viral Vector Manufacturing, AAV Scalability, and Gene Therapy CMC · Platform R&D to early process demonstration
Copenhagen cell-free AAV manufacturing platform biotech with named co-founder Co-CEO, HCVC- and BII-backed 5.2 million USD pre-seed, and an active Leiden R&D site.
- Lead
- Jordan Turnbull (verified ↗)
- Address
- BioInnovation Institute, Tuborg Havnevej 19, 2900 Hellerup, Denmark (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Platform R&D to early process demonstration
- Capabilities
- Cell-Free AAV Production Platform · Scalable Gene Therapy Manufacturing · Copenhagen and Leiden Dual-Site Operations
- Founded
- 2022
- Headcount
- 1-10
Clinical profileSTATUS: VERIFIED APRIL 2026
Jordan Turnbull
Co-Chief Executive Officer and Co-Founder
Full addressBioInnovation Institute, Tuborg Havnevej 19, 2900 Hellerup, Denmark
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source
Leiden Bioscience Park announcement of Fuse Vectors operations with Hellerup headquarters.
Open sourcePlatform R&D to early process demonstration
Copenhagen, Denmark. Cell-Free Viral Vector Manufacturing, AAV Scalability, and Gene Therapy CMC. Review completed on 24 Apr 2026.
Danish Medicines Agency, EMA, and CBG-MEB (NL) for future clinical advancement
Pre-seed platform stage, BII Copenhagen portfolio, Leiden Bioscience Park presence
Cell-Free Viral Vector Manufacturing, AAV Scalability, and Gene Therapy CMC
Copenhagen cell-free AAV manufacturing platform biotech with named co-founder Co-CEO, HCVC- and BII-backed 5.2 million USD pre-seed, and an active Leiden R&D site.
Editorial note
Fuse Vectors combines a BioInnovation Institute Copenhagen headquarters with a Leiden R&D site and a named co-founder Co-CEO, targeting the AAV manufacturing bottleneck through cell-free viral-vector production.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Cell-Free AAV Production Platform
Scalable Gene Therapy Manufacturing
Copenhagen and Leiden Dual-Site Operations
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Cell-free AAV production system
Leiden R&D laboratory
BII Copenhagen incubator space
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Fuse Vectors ApS located?
- Fuse Vectors ApS operates from BioInnovation Institute, Tuborg Havnevej 19, 2900 Hellerup, Denmark, Copenhagen, Denmark.
- Who runs Fuse Vectors ApS?
- Fuse Vectors ApS is led by Jordan Turnbull, Co-Chief Executive Officer and Co-Founder. Verified 24 Apr 2026.
- What does Fuse Vectors ApS do?
- Copenhagen cell-free AAV manufacturing platform biotech with named co-founder Co-CEO, HCVC- and BII-backed 5.2 million USD pre-seed, and an active Leiden R&D site. Core capabilities: Cell-Free AAV Production Platform, Scalable Gene Therapy Manufacturing, Copenhagen and Leiden Dual-Site Operations.
Editorial context
Related technical briefs
Briefs that name Copenhagen as a covered market or city.